NONOF
NOVO NORDISK A/S B NEW
stockOTC
novo nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. this heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. headquartered in denmark, novo nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries. for more information, visit novonordisk.com, facebook, twitter, instagram, youtube. this page isn't intended for discussions about products. as such, postings or comments that contain product discussions may be removed. this page is for discussions about novo nordisk and its subsidiaries and the initiatives and projects we are involved in. while we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. any questions specific to products should be made to your healthcare professional. if you w
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.38 | 2026-09-28 | -3.57% | -0.843 |
| 1M | 46.31 | 2026-09-04 | -20.07% | -0.581 |
| 3M | 49.58 | 2026-07-06 | -25.35% | -0.600 |
| 6M | 35.58 | 2026-04-06 | +4.03% | -0.059 |
| 1Y | 59.78 | 2025-10-03 | -38.09% | 0.608 |
| 2Y | 114.04 | 2024-10-04 | -67.55% | — |
| 5Y | 47.80 | 2021-10-04 | -22.57% | 0.361 |
NOVO NORDISK A/S B NEW (OTC:NONOF) stock price today is $37.01, and today's volume is 14,285. NONOF is down 0.986% today. The 30 day average volume is 132,207. NONOF market cap is $125.47B with 3.39B shares outstanding.